The expanding spectrum of clinical phenotypes associated with PSTPIP1 mutations: from PAPA to PAMI syndrome and beyond

Publication date

2018-04-01

Authors

Klötgen, H. W.
Beltraminelli, H.
Yawalkar, N.
van Gijn, Marielle E.ISNI 0000000396381532
Holzinger, D.
Borradori, L.

Editors

Advisors

Supervisors

Document Type

Letter

Collections

Open Access logo

License

taverne

Abstract

Mutations in the PSTPIP1 gene encoding proline-serine-threonine-phosphatase interactive protein 1 were first identified in an autosomal dominant syndrome called PAPA associated with pyogenic sterile arthritis, pyoderma gangrenosum (PG) and cystic acne.1,2 . We report a patient with an autoinflammatory syndrome called PSTPIP1-associated myeloid-related proteinemia inflammatory (PAMI) syndrome.3 A 23-year-old man had a 3-year-history of skin ulcerations. This article is protected by copyright. All rights reserved.

Keywords

Taverne, Dermatology

Citation

Klötgen, H W, Beltraminelli, H, Yawalkar, N, van Gijn, M E, Holzinger, D & Borradori, L 2018, 'The expanding spectrum of clinical phenotypes associated with PSTPIP1 mutations : from PAPA to PAMI syndrome and beyond', British Journal of Dermatology, vol. 178, no. 4, pp. 982-983. https://doi.org/10.1111/bjd.16136